QURE
uniQure N.V.
Healthcare •
Biotechnology •
stocks •
XNAS
• usd
$26.65
$-1.15
(-4.14%)
Loading...
SMA 20: -
SMA 50: -
SMA 200: -
| General | Valuation | Profitability | Financial Health | Trading | Ownership |
|---|---|---|---|---|---|
| Market Cap | $1.66B | EPS (ttm) | $-4.40 | Current Price | $26.65 |
| Enterprise Value | $1.50B | Forward EPS | $-3.28 | Previous Close | $27.80 |
| P/E Ratio | - | ROA | -13.89% | 52W High | $71.50 |
| Forward P/E | -8.13 | ROE | -165.27% | 52W Low | $7.76 |
| PEG Ratio | - | Gross Margin | - | 50 Day Avg | $23.79 |
| P/S Ratio | 105.39 | Operating Margin | -1329.72% | 200 Day Avg | $24.35 |
| P/B Ratio | 7.24 | Profit Margin | - | Volume | 2.24M |
| EV/EBITDA | -9.70 | Current Ratio | 7.12 | Avg Volume | 2.65M |
| EV/Sales | 95.07 | Quick Ratio | 6.94 | Beta | 0.67 |
| Employees | 209.00 | Debt/Equity | 232.43 | Shares Outstanding | 62.29M |
| Sector | Healthcare | Total Debt | $531.66M | Float Shares | 45.99M |
| Industry | Biotechnology | Total Cash | $694.24M | Short Float | 18.79% |
| Optionable | Yes | Cash/Share | $11.14 | Short Ratio | 4.70 |
| Dividend Yield | - | Book Value/Share | $3.68 | % Held by Insiders | 5.33% |
| Target Price | $53.29 | Revenue (TTM) | $15.75M | % Held by Institutions | 95.07% |